Advertisement

Topics

Metastatic Breast Cancer Network Company Profile

16:14 EDT 23rd September 2017 | BioPortfolio


News Articles [7284 Associated News Articles listed on BioPortfolio]

More Women Are Living Longer With Metastatic Breast Cancer, But Questions Remain

Metastatic breast cancer patients represent a significant group within the U.S. population who live with a chronic or terminal condition and stand to benefit from new treatments.

First Look at New CDK 4/6 Data in Metastatic Breast Cancer

ASCO 2017 featured a number of important studies looking at the role of CDK 4/6 inhibitors in patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Medscape Oncology

New CDK4/6i Data Move Metastatic Breast Cancer Field Forward

At ASCO 2017, the MONARCH-3, PALOMA-1, AND TREnd trials shed light on the efficacy of new CDK4/6 inhibitors for metastatic breast cancer. Medscape Oncology

Metastatic breast cancer cells use hedgehog to 'evilize' docile neighbors

(University of Colorado Anschutz Medical Campus) A University of Colorado Cancer Center study published today in Nature Communications shows that metastatic breast cancer cells signal neighboring cell...

Study estimates number of US women living with metastatic breast cancer

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of ...

A new HER2 mutation, a clinical trial and a promising diagnostic tool for metastatic breast cancer

(Baylor College of Medicine) A phase II clinical trial of neratinib in patients with metastatic breast cancer carrying a HER2 mutation produces encouraging results in that about 30 percent of patients...

Genetic vs immune strategies in breast cancer

Prof André speaks with ecancer at IMPAKT 2017 about establishing genomic triggers and drug targeting against metastatic breast cancer. He describes acquired and evolved genetic alterations as infl...

Lilly Receives Priority Review for Advanced Breast Cancer Therapy

NewsFDA grants priority review for Lilly's abemaciclib for the treatment of advanced breast cancer. Advanced breast cancer includes metastatic breast cancer that has spread to other parts of the body...

Drugs and Medications [554 Associated Drugs and Medications listed on BioPortfolio]

Halaven [Eisai Inc.]

These highlights do not include all the information needed to use HALAVEN™ safely and effectively. See full prescribing information for HALAVEN. HALAVEN™ (eribulin mesylate) Injection For intraven...

Gemcitabine hydrochloride [APP Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

Gemcitabine [Hospira, Inc.]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

Gemcitabine [Hospira, Inc.]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

PubMed Articles [12550 Associated PubMed Articles listed on BioPortfolio]

Metastatic Breast Cancer.

Despite advances in breast cancer screening, diagnosis, and treatment, nearly 12% of patients with a diagnosis of breast cancer eventually develop metastatic disease, or breast cancer that has spread ...

Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.

Except for meeting the individual palliative need, the benefit of breast surgery in primary metastatic breast cancer (PMBC), also known as de novo metastatic breast cancer, on long-term outcomes remai...

Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"

MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.

MicroRNA-7 (miR-7) has been observed as a potent tumour suppressor in multiple cancer types including breast cancer. The aim of this study was to investigate the response sensitivities of metastatic b...

Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes.

Metastatic breast cancer is a leading cause of mortality in women, partly on account of brain metastases. However, the mechanisms by which cancer cells cross the blood-brain barrier remain undeciphere...

Clinical Trials [12125 Associated Clinical Trials listed on BioPortfolio]

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

The lack of non-overlapping toxicities between the two drugs, the ease of all oral drug administration, and the possibility for antitumor synergy make exploration of this combination regim...

Advanced Breast Cancer and Lifestyle Exercise Study

About 5% of breast cancers are metastatic at diagnosis and 20-30% of localized breast cancer become secondarily metastatic.Thanks to recent therapeutic advances, the median survival ranges...

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

RATIONALE: Studying samples of blood from patients with metastatic breast cancer in the laboratory may help doctors identify biomarkers related to breast cancer and learn more about how br...

First Line Metastatic Breast Cancer Treatment (ESMERALDA)

The efficacy of eribulin is now well known in metastatic breast cancer. Furthermore, a phase III combine study ( chemo + bev)in metastatic first line shown a gain in PFS with no extra tox...

Understanding Value in Metastatic Breast Cancer

The overall objective of this project is to gain knowledge about out-of-pocket (OOP) expenses and lost opportunity costs among metastatic breast cancer (MBC) patients. To achieve this obje...

Companies [2106 Associated Companies listed on BioPortfolio]

Metastatic Breast Cancer Network

A&G Pharmaceutical Incorporated

A&G Pharmaceutical, Inc. (A&G) was incorporated in Delaware on June 6, 2000, as a "C" Corporation, to make use of two proprietary technologies that are unique to the Company. A&G is located in Baltimo...

Brides Against Breast Cancer

Brides Against Breast Cancer (BABC) is a wholly owned affiliate of the Center for Building Hope, headquartered in Sarasota, FL. The Center offers free information, programs and se...

Susan G. Komen for the Cure and Canadian Breast Cancer Foundation

The Canadian Breast Cancer Foundation was founded in 1986 by a group of volunteers and has become the leading national volunteer-based organization in Canada dedicated to creating...

National Breast Cancer Awareness Month

In the United States, an estimated 192,370 women and 1,910 men will be diagnosed with new cases of breast cancer in 2009. Breast cancer ranks second as a cause of cancer death in women (after lung can...

More Information about "Metastatic Breast Cancer Network" on BioPortfolio

We have published hundreds of Metastatic Breast Cancer Network news stories on BioPortfolio along with dozens of Metastatic Breast Cancer Network Clinical Trials and PubMed Articles about Metastatic Breast Cancer Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Metastatic Breast Cancer Network Companies in our database. You can also find out about relevant Metastatic Breast Cancer Network Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record